As we age, our cells accumulate genetic changes—mutations—some of which open the door to cancer. Scientists call these ...

Diseases like cancer or neurodegeneration are known to arise from genetic misfires. But treating such complex conditions hasn ...

FORMS, AND YOU MAY HAVE HEARD OF SOME GENE MUTATIONS LIKE BRCA1 OR BRCA2, BUT THERE’S ANOTHER ONE THAT YOU MAY NOT HAVE HEARD OF, AND IT’S CHEK2. MERCY MEDICAL CENTER DOCTOR NEIL FRIEDMAN JOINS US NOW ...

An international group led by researchers from the RIKEN Center for Integrative Medical Sciences (IMS) in Japan has ...

There are about 80,000 new cases of bladder cancer every year in the US alone. About one-third of cases are diagnosed at late stages when the disease is hard to treat. Scientists have now learned more ...

The gene p53 acts as a tumor suppressor and often is called the ‘guardian of the genome.’ This gene is central to maintaining genomic stability, which prevents mutations from accumulating and leading ...

Today, doctors are increasingly looking at the genetic makeup of each patient’s tumor to guide treatment decisions.

The Scottish Medicines Consortium has approved osimertinib for adults with unresectable stage III EGFR-mutant NSCLC whose disease has not progressed after platinum-based chemoradiation.

At SGO 2026, Alison Schram, MD, highlighted first-in-class tumor suppressor reactivation and emphasized early NGS testing in ...

Mutations within the Complex Proteins Associated With Set1 (COMPASS) family of histone lysine methyltransferases are frequently found in many human diseases including cancer. Increasingly, these ...

Scientists have linked roughly five percent of adult cancers to mutations in genes called FOCAD and TTC37. Another gene known as PELO is crucial to these cancers, and when the action of that gene is ...

Researchers found strong genetic similarities between cat and human cancers, identifying key mutations and potential ...